Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (отваря нов прозорец)

Abdelrazik N, Fouda M

Източник‎: Hematology 2007;12(6):533-41.

Статията е индексирана‎: PubMed 17852440

DOI‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 (отваря нов прозорец)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (отваря нов прозорец)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Източник‎: Cancer 2012;118(3):848-55.

Статията е индексирана‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (отваря нов прозорец)

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. (отваря нов прозорец)

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

Източник‎: Pediatr Hematol Oncol 2008;25(6):509-21.

Статията е индексирана‎: PubMed 18728970

DOI‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 (отваря нов прозорец)

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. (отваря нов прозорец)

Durmaz O, Demirkaya M, Sevinir B

Източник‎: Pediatr Hematol Oncol 2011;28(6):461-8.

Статията е индексирана‎: PubMed 21707225

DOI‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 (отваря нов прозорец)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (отваря нов прозорец)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Източник‎: J Clin Oncol 2010;28(13):2239-45.

Статията е индексирана‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (отваря нов прозорец)

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. (отваря нов прозорец)

Hassan BA, Yusoff ZB

Източник‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

Статията е индексирана‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 (отваря нов прозорец)

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. (отваря нов прозорец)

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

Източник‎: Curr Med Res Opin 2009;25(9):2109-20.

Статията е индексирана‎: PubMed 19601709

DOI‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 (отваря нов прозорец)

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. (отваря нов прозорец)

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

Източник‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

Статията е индексирана‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 (отваря нов прозорец)

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. (отваря нов прозорец)

Hiradfar A, Banihosseinian M

Източник‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

Статията е индексирана‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 (отваря нов прозорец)

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. (отваря нов прозорец)

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Източник‎: Pediatr Blood Cancer 2009;53(1):7-12.

Статията е индексирана‎: PubMed 19229970

DOI‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 (отваря нов прозорец)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (отваря нов прозорец)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Източник‎: Cancer 2013;119(1):107-14.

Статията е индексирана‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (отваря нов прозорец)

Erythropoietic growth factors for children with cancer: a systematic review of the literature. (отваря нов прозорец)

Mystakidou K, Potamianou A, Tsilika E

Източник‎: Curr Med Res Opin 2007;23(11):2841-7.

Статията е индексирана‎: PubMed 17910805

DOI‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 (отваря нов прозорец)

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (отваря нов прозорец)

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

Източник‎: J Clin Oncol 2006;24(22):3583-9.

Статията е индексирана‎: PubMed 16877725

DOI‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 (отваря нов прозорец)

The role of recombinant erythropoietin in childhood cancer. (отваря нов прозорец)

Shankar AG

Източник‎: Oncologist 2008;13(2):157-66.

Статията е индексирана‎: PubMed 18305061

DOI‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 (отваря нов прозорец)

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. (отваря нов прозорец)

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

Източник‎: MEDICC Rev 2010;12(3):27-31.

Статията е индексирана‎: PubMed 20697335

DOI‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 (отваря нов прозорец)

A single institutional experience: is epoetin alpha effective in anemic children with cancer? (отваря нов прозорец)

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

Източник‎: Pediatr Hematol Oncol 2004;21(1):1-8.

Статията е индексирана‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 (отваря нов прозорец)

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. (отваря нов прозорец)

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

Източник‎: Pediatr Hematol Oncol 2014;31(5):442-7.

Статията е индексирана‎: PubMed 24088186

DOI‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 (отваря нов прозорец)

Early epoetin alfa treatment in children with solid tumors. (отваря нов прозорец)

Zoubek A, Kronberger M

Източник‎: Med Pediatr Oncol 2002;39(4):459-62.

Статията е индексирана‎: PubMed 12203664

DOI‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 (отваря нов прозорец)

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. (отваря нов прозорец)

Crary SE, Hall K, Buchanan GR.

Източник‎: Pediatr Blood Cancer 2011;56(4):615-9.

Статията е индексирана‎: PubMed 21298748

DOI‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 (отваря нов прозорец)

Intravenous iron sucrose for children with iron deficiency anemia. (отваря нов прозорец)

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

Източник‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

Статията е индексирана‎: PubMed 28562517

DOI‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 (отваря нов прозорец)

Advances in Pediatric Intravenous Iron Therapy. (отваря нов прозорец)

Mantadakis E.

Източник‎: Pediatr Blood Cancer 2016;63(1):11-6.

Статията е индексирана‎: PubMed 26376214

DOI‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 (отваря нов прозорец)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (отваря нов прозорец)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Източник‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Статията е индексирана‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (отваря нов прозорец)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (отваря нов прозорец)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Източник‎: J Clin Oncol 2008;26(10):1619-25.

Статията е индексирана‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (отваря нов прозорец)

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. (отваря нов прозорец)

Plummer ES, Crary SE, McCavit TL, Buchanan GR

Източник‎: Pediatr Blood Cancer 2013;60(11):1747-52.

Статията е индексирана‎: PubMed 23832487

DOI‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 (отваря нов прозорец)